Prostate Cancer - Results from #26660

Locally advanced prostate cancer: A population-based study of treatment patterns - Abstract December 13, 2011

Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer - Abstract December 13, 2011

The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume - Abstract December 13, 2011

Association between VHL single nucleotide polymorphism (rs779805) and the susceptibility to prostate cancer in Chinese - Abstract December 13, 2011

Relationship between PSA kinetics and [(18)F]fluorocholine PET/CT detection rates of recurrence in patients with prostate cancer after total prostatectomy - Abstract December 13, 2011

A replication study examining novel common single nucleotide polymorphisms identified through a prostate cancer genome-wide association study in a Japanese population - Abstract December 13, 2011

East meets West: Ethnic differences in prostate cancer epidemiology between East Asians and Caucasians - Abstract December 13, 2011

Editor's Commentary - Late gastrointestinal toxicities following radiation therapy for prostate cancer December 13, 2011

Panel endorses active monitoring and delay of treatment for low-risk prostate cancer December 13, 2011

Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation - Abstract December 12, 2011

Biological evaluation of RGDfK-gold nanorod conjugates for prostate cancer treatment - Abstract December 12, 2011

Robotic-assisted laparoscopic prostatectomy for high-risk prostate cancer: Technical considerations and review of the literature - Abstract December 12, 2011

Cancer risk and behavioral factors, comorbidities, and functional status in the US elderly population - Abstract December 12, 2011

Cytotoxic activity of peripheral blood mononuclear leukocytes, activated by interleukin-2/β-cyclodextrin nanocomposition against androgen receptor-negative prostate cancers - Abstract December 12, 2011

Management options in advanced prostate cancer: What is the role for sipuleucel-T - Abstract December 12, 2011

Integration of regulatory networks by NKX3.1 promotes androgen-dependent prostate cancer survival - Abstract December 12, 2011

Comparison of template-matching and singular-spectrum-analysis methods for imaging implanted brachytherapy seeds - Abstract December 12, 2011

Novel vitamin D analogs for prostate cancer therapy - Abstract December 12, 2011

Biochemical control with radiotherapy improves overall survival in intermediate and high-risk prostate cancer patients who have an estimated 10-year overall survival of >90% - Abstract December 9, 2011

Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer - Abstract December 9, 2011

Page 1334 of 1437